With a market cap of $109.2 billion, Boston Scientific Corporation (BSX) is a medical devices industry that specializes in interventional medical specialties. The Massachusetts-based company develops, manufactures, and markets diverse products globally for cardiovascular, rhythm and neuro, and MedSurg specialties.
Shares of the medical device manufacturer have outperformed the broader market over the past 52 weeks. BSX has gained 38.7% over this time frame, while the broader S&P 500 Index ($SPX) has rallied 28.3%. In 2024 alone, shares of BSX are up 28.8%, compared to SPX's 11.3% gains on a YTD basis.
